Forge an innovative path towards a cure by tapping into our decades of experience in delivering gene therapy solutions that can help you navigate obstacles and challenges. Our end-to-end solutions, high quality products and services are here to support you at every step of the way, from gene therapy research to gene therapy commercialization.
Connect to the innovative solutions designed to accelerate your AAV vector development and manufacturing workflows. We offer complete upstream and downstream solutions that span plasmid development, viral vector production, purification, and analytics.
Accelerate your gene modified cell therapies and gene therapies with robust workflow solutions. Explore upstream, downstream, and analytical solutions to support your process.
Download our brochure to learn more about our end-to-end gene therapy workflow solutions.
Our goal is to support you at every stage of your gene therapy development process. We can provide regulatory documentation support, custom gene therapy products and services and manufacturing scale up assistance to help you reach your gene therapy goals.
Protect your irreplaceable gene therapy materials by connecting to expert advice and optimized solutions for transporting, storing, and handling specialized biological samples and material, from ambient to ultra low temperatures.
Accurate measurement of process-related impurities and microbial contaminants, as well as in-process analytical testing and environmental monitoring are essential to gene therapy lot release development.
Our state of the art production suites in multiple manufacturing locations are dedicated to commercial quality GMP plasmid production, helping you attain shorter lead times and flexibility in manufacturing timelines when there are changes in your schedule.
Our deep technical and analytical expertise helps ensure quality and compliance while operating with transparency and flexibility. Connect to a viral vector CDMO with over 20 years of experience developing processes and producing cGMP viral vectors.
Our high quality raw materials are specifically designed to accelerate the development and manufacture of oligonucelotide and mRNA therapeutics. Connect to a proven partner who will help you achieve your goal of rapidly bringing these revolutionary new medicines to market.
The AAV-MAX Helper Free AAV Production System enables a smooth transition from discovery through manufacturing, offering one optimized, scalable platform with research grade and cGMP manufactured reagent options.
A plate based digital PCR (dPCR) platform powered by proprietary microfluidic array plate (MAP) technology that enables all the necessary steps for dPCR compartmentalizing, thermal cycling, and data acquisition to be conducted on a single instrument.
POROS CaptureSelect AAVX Affinity Resin is engineered to address the high selectivity and capacity requirements for large scale downstream purification of a broad range of naturally occurring and synthetic AAV serotypes used for gene therapy applications.
Intended use of the products mentioned on this page vary. For specific intended use statements please refer to the product label.
